BTIG analyst David Larsen maintained a Hold rating on Doximity (DOCS – Research Report) yesterday. The company’s shares closed last Friday at $28.04.
According to TipRanks, Larsen is an analyst with an average return of -6.6% and a 34.68% success rate. Larsen covers the Healthcare sector, focusing on stocks such as LifeMD, Apollo Medical Holdings, and Health Catalyst.
Currently, the analyst consensus on Doximity is a Hold with an average price target of $26.14, which is a -6.78% downside from current levels. In a report released today, Bank of America Securities also upgraded the stock to a Hold with a $29.00 price target.
See today’s best-performing stocks on TipRanks >>
DOCS market cap is currently $5.21B and has a P/E ratio of 48.16.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Doximity (DOCS) Company Description:
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Read More on DOCS:
